Among the known common molecular changes in intestinal-type gastric cancer are enhanced expression of cyclooxygenase-2 (COX2) and diminished expression of the mucous-associated protein trefoil factor 1 (TFF1). This evidence concerns the gene TFF1 and gastric cancer.